4DMedical Ltd
ASX:4DX
4DMedical Ltd
ASX:4DX
Price:
4.075
AUD
0.62%
Market Closed
Market Cap:
AU$2.1B
Income Statement
Earnings Waterfall
4DMedical Ltd
4DMedical Ltd
Income Statement
4DMedical Ltd
4DMedical Ltd
Currency: AUD
| Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Interest Expense |
8
|
10
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
0
-77%
|
0
-23%
|
0
+3%
|
1
+373%
|
1
+31%
|
1
-48%
|
1
+43%
|
4
+266%
|
6
+56%
|
6
0%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
-40%
|
0
+88%
|
0
+19%
|
0
+88%
|
1
+126%
|
1
+8%
|
1
+42%
|
4
+261%
|
5
+56%
|
5
-2%
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(14)
|
(20)
|
(19)
|
(21)
|
(25)
|
(29)
|
(32)
|
(33)
|
(38)
|
(45)
|
(42)
|
|
| Selling, General & Administrative |
(14)
|
(19)
|
(20)
|
(24)
|
(30)
|
(34)
|
(37)
|
(40)
|
(43)
|
(46)
|
(46)
|
|
| Research & Development |
0
|
(1)
|
(2)
|
(4)
|
(4)
|
(6)
|
(4)
|
(2)
|
(1)
|
1
|
(1)
|
|
| Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
|
| Other Operating Expenses |
1
|
1
|
4
|
8
|
11
|
13
|
12
|
13
|
10
|
5
|
10
|
|
| Operating Income |
(14)
N/A
|
(20)
-44%
|
(19)
+5%
|
(21)
-10%
|
(24)
-18%
|
(28)
-15%
|
(31)
-11%
|
(32)
-1%
|
(35)
-10%
|
(39)
-13%
|
(37)
+7%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
(8)
|
(10)
|
(3)
|
0
|
(0)
|
(0)
|
0
|
1
|
1
|
(0)
|
7
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
(1)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(22)
N/A
|
(30)
-35%
|
(21)
+28%
|
(21)
+3%
|
(25)
-19%
|
(28)
-15%
|
(31)
-10%
|
(30)
+2%
|
(36)
-18%
|
(40)
-10%
|
(30)
+24%
|
|
| Net Income | ||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Income from Continuing Operations |
(22)
|
(30)
|
(21)
|
(21)
|
(25)
|
(28)
|
(31)
|
(31)
|
(36)
|
(40)
|
(30)
|
|
| Net Income (Common) |
(22)
N/A
|
(30)
-35%
|
(21)
+28%
|
(21)
+3%
|
(25)
-19%
|
(28)
-15%
|
(31)
-11%
|
(31)
+2%
|
(36)
-17%
|
(40)
-10%
|
(30)
+24%
|
|
| EPS (Diluted) |
-0.08
N/A
|
-0.11
-38%
|
-0.08
+27%
|
-0.07
+12%
|
-0.08
-14%
|
-0.1
-25%
|
-0.1
N/A
|
-0.09
+10%
|
-0.1
-11%
|
-0.1
N/A
|
-0.07
+30%
|
|
Switch to:
Switch to:
See Also
Discover More
